Urokinase-streptokinase embolism trial. Phase 2 results. A cooperative study.
D006328:Cardiac Catheterization; D002302:Cardiac Output; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006400:Hematocrit; D006470:Hemorrhage / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D008875:Middle Aged; D011651:Pulmonary Artery / Q000000981:diagnostic imaging; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000188:drug therapy*; D011859:Radiography; D011877:Radionuclide Imaging; D013300:Streptokinase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D005343:Fibrinolytic Agents; D006493:Heparin; D013300:Streptokinase